The Boehringer Ingelheim group of companies, headquartered in Ingelheim,
Germany, is one of the 20 leading pharmaceutical corporations in the
world.
Boehringer Ingelheim, which has some 140 affiliated companies in 42 countries
worldwide, focuses on hum pharmaceuticals and animal health. The human
pharmaceuticals business, which accounts for 95% of sales, is comprised of
prescription medicines, consumer healthcare products, and chemicals and
biopharmaceuticals for industrial customers. Research and development,
production and distribution facilities are located around the globe.
Every year Boehringer Ingelheim invests about 18% of net sales in the
research and development of medicinal products, which is almost a fifth of
Prescription Medicine's net sales.
Boehringer Ingelheim has been operating in New Zealand since 1973.
(back to top)
